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Abstract
Hyperlipidemic apolipoprotein E (APOE) knockout mice show an enhanced level of adrenal-derived anti-inflammatory
glucocorticoids. Here we determined in APOE knockout mice the impact of total removal of adrenal function through
adrenalectomy (ADX) on two inflammation-associated pathologies, endotoxemia and atherosclerosis. ADX mice
exhibited 91% decreased corticosterone levels (P<0.001), leukocytosis (WBC count: 10.0 ± 0.4 x 10E9/L vs 6.5 ± 0.5
x 10E9/L; P<0.001) and an increased spleen weight (P<0.01). FACS analysis on blood leukocytes revealed
increased B-lymphocyte numbers (55 ± 2% vs 46 ± 1%; P<0.01). T-cell populations in blood appeared to be more
immature (CD62L+: 26 ± 2% vs 19 ± 1% for CD4+ T-cells, P<0.001 and 58 ± 7% vs 47 ± 4% for CD8+ T-cells,
P<0.05), which coincided with immature CD4/CD8 double positive thymocyte enrichment. Exposure to
lipopolysaccharide failed to increase corticosterone levels in ADX mice and was associated with a 3-fold higher
(P<0.05) TNF-alpha response. In contrast, the development of initial fatty streak lesions and progression to advanced
collagen-containing atherosclerotic lesions was unaffected. Plasma cholesterol levels were decreased by 35%
(P<0.001) in ADX mice. This could be attributed to a decrease in pro-atherogenic very-low-density lipoproteins
(VLDL) as a result of a diminished hepatic VLDL secretion rate (-24%; P<0.05). In conclusion, our studies show that
adrenalectomy induces leukocytosis and enhances the susceptibility for endotoxemia in APOE knockout mice. The
adrenalectomy-associated rise in white blood cells, however, does not alter atherosclerotic lesion development
probably due to the parallel decrease in plasma levels of pro-atherogenic lipoproteins.
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Introduction
Apolipoprotein E (APOE) is a multi-functional anti-
atherogenic molecule secreted by hepatocytes and, to a lesser
extent, bone marrow-derived cells such as macrophages.
APOE facilitates the efflux of cholesterol from lipid-laden
macrophages [1], lowers cellular lipid oxidation [2], and inhibits
the proliferation and migration of smooth muscle cells [3].
However, APOE is best known for its anti-atherogenic effect on
the metabolism of lipoproteins. APOE is primarily associated
with lipoprotein remnants that are cleared from the blood
circulation through binding to heparan sulfate proteoglycans
(HSPG) for subsequent uptake by the LDL receptor (LDLR)
and LDL receptor-related protein 1 (LRP1) located on
hepatocytes [4]. Wild-type mice are not susceptible to
atherosclerosis. In contrast, disruption of total body APOE
function, i.e. in genetically modified APOE knockout mice, is
associated with severe hyperlipidemia and spontaneous
development of atherosclerotic lesions already on a regular
chow low fat diet without added cholesterol [5]. APOE knockout
mice do also exhibit an enhanced susceptibility to endotoxemia
[6,7], which supports the concept that the presence of
hyperlipidemia renders these mice more prone for (lethal)
inflammation.
Glucocorticoids, also known as stress hormones, are a class
of steroids that are secreted by cortical cells of the zona
fasciculata within the adrenals in response to activation of the
hypothalamus-pituitary-adrenal (HPA)-axis. Glucocorticoids
represent a class of potent immunosuppressive molecules
(reviewed by Baschant and Tuckermann [8]). Glucocorticoids
suppress neutrophil rolling, adhesion and transmigration,
suppress macrophage activation and dendritic cell maturation
and migration, and induce apoptosis of dendritic cells and
lymphocytes. Our previous studies in low-density lipoprotein
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(LDL) receptor knockout mice have suggested that
glucocorticoids through their immunosuppressive action protect
against the development of atherosclerotic lesions upon
feeding an inflammatory cholate-containing high cholesterol/
high fat diet that stimulates adrenal steroidogenesis and
induces severe hyperlipidemia [9]. Interestingly, findings by
Raber et al. [10] and Grootendorst et al. [11] have indicated
that APOE knockout mice already when fed a standard low fat
chow diet display a higher basal level and action of
glucocorticoids. These combined findings suggest that the
enhanced glucocorticoid action may represent an inherited
protective anti-inflammatory response to the genetic
hyperlipidemia-associated pro-inflammatory / pro-atherogenic
status in APOE knockout mice. To validate this hypothesis, in
the current study we determined the impact of removal of the
glucocorticoid function in APOE knockout mice on the outcome
of two inflammation-associated pathologies, endotoxemia and
atherosclerosis. Our studies show that adrenalectomy induces
leukocytosis and enhances the susceptibility for endotoxemia
in APOE knockout mice. The adrenalectomy-associated rise in
white blood cells, however, does not alter atherosclerotic lesion
development probably due to the parallel decrease in plasma
levels of pro-atherogenic lipoproteins.
Materials and Methods
Mice
Homozygous APOE knockout mice were obtained from The
Jackson Laboratory, crossed back to the C57BL/6 background
(>8 generations) and bred in house at the Gorlaeus
Laboratories, Leiden, The Netherlands. Since (1) female mice
display both a higher basal corticosterone level [12,13] and a
faster initial development of atherosclerotic lesions as
compared to male mice under chow diet feeding conditions [14]
and (2) the response of the hypothalamus-pituitary-adrenal axis
is independent of the estrous cycle in mice [15], we used
female APOE knockout mice that were fed a regular low-fat
chow diet in all our experiments.
Mice were bilaterally adrenalectomized under isoflurane
inhalation anesthesia through a dorsal midline skin incision and
lateral retroperitoneal incisions. All efforts were made to
minimize suffering. Parallel control (SHAM) operations were
executed where the adrenals were touched but otherwise left
intact. After closure of skin wounds using michel suture clip,
operated mice were left separated from each other overnight
for efficient wound healing and were subsequently housed with
4 similarly operated mice per cage. During the complete study,
all mice were given 0.9% NaCl and normal water ad libitum and
were regularly and identically handled. At the end of the study,
no signs of endogenous adrenal regeneration were
macroscopically visible in any of the adrenalectomized mice.
Animal experiments were performed in a temperature and
light cycle (12h light/12h dark) controlled room at the Gorlaeus
Laboratories of the Leiden/Amsterdam Center for Drug
Research in accordance with the National Laws. All
experimental protocols were approved by the Ethics Committee
for Animal Experiments of Leiden University (Ethics protocol
#10095).
Corticosterone measurements
Blood samples for basal corticosterone analysis were drawn
through tail chop between 9:00 and 10:00 AM (2- to 3h in the
light period). Levels of corticosterone were determined using a
125I radio immuno assay (RIA) with a lower detection limit of 5
ng/ml, according to the manufacturer’s specifications (MP
Biomedials). During blood draws mice were restrained for a
maximum of 30 seconds.
Blood cell analysis
At sacrifice (8 weeks post surgery) total white blood cells
counts and the distribution over different subclasses of white
blood cells were routinely measured using an automated
SYSMEX XT-2000iV Veterinary Heamatology analyzer
(SYSMEX Corporation). Verification of effects on specified
white blood cell subclasses was performed using fluorescence
activated cell sorting (FACS analysis) by staining cells with
appropriate antibodies (CD11b, Ly6G, CD4, CD8, CD19,
CD86, CD62L, all obtained form eBioscience, Belgium). For
this purpose, blood was lysed using 0.83% NH4CL in 0.01 M
Tris/HCL pH 7.2. Single-cell suspensions from spleen and
thymus were obtained by squeezing the organs through a 70-
µm cell strainer. Subsequently 300.000 cells were stained with
the indicated antibodies. FACS analysis was performed on the
FACSCalibur (Becton Dickinson, Mountain View, CA).
Identification of specific leukocyte subsets was primarily based
upon the indicated fluorescent antibody signals, but was further
validated by checking the size and granularity of the tagged
cells in the forward/side scatter plots. Data were analyzed
using Cell Quest software.
Lipopolysaccharide challenge
Mice were intravenously injected at 0900h with 50 μg/kg
lipopolysaccharide (LPS) from Salmonella minnesota R595
(List Biological Laboratories Inc, Hornby, Canada) into the tail
vein. Blood samples were collected after 30, 60, 90, and 120
minutes for cytokine analysis.
Cytokine analyses
TNF-alpha and IL-6 protein levels in plasma were
determined by ELISA (OptEIA kit, BD Biosciences Pharmingen,
San Diego, CA) according to the suppliers protocols.
Aortic root atherosclerotic lesion analysis
The arterial tree was perfused in situ with PBS (with the
pressure of 100 mm Hg) for 10 minutes via a cannula in the left
ventricular apex. The heart plus aortic root was excised and
stored in 3.7% neutral-buffered formalin (Formalfixx ®,
Shandon Scientific Ltd., UK). The atherosclerotic lesion areas
in Oil red O stained cryostat sections of the aortic root were
quantified using the Leica image analysis system, consisting of
a Leica DMRE microscope coupled to a video camera and
Leica Qwin Imaging software (Leica Ltd., Cambridge, UK).
Mean lesion area (μm2) was calculated from >5 Oil red O-
stained sections, starting at the appearance of the tricuspid
valves. Lesion collagen content was determined using
Masson’s Trichrome staining. All quantifications were done
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blinded by computer aided morphometric analysis using the
Leica image analysis system.
Plasma lipids
To determine the postprandial triglyceride response, mice
were bled at 900h via the tail for basal plasma lipid values and
subsequently given an oral dose of 200 μl olive oil. Blood
samples were collected after 1, 2, 3, and 4 hours and plasma
concentrations of total cholesterol and triglycerides were
determined using enzymatic colorimetric assays (Roche
Diagnostics). The basal lipoprotein distribution profile was
analyzed by fractionation of 30 μl pooled plasma using a
Superose 6 column (3.2 × 300 mm, Smart-system, Pharmacia).
Total cholesterol, content of the effluent was determined using
enzymatic colorimetric assays (Roche Diagnostics).
VLDL triglyceride production
At 9:00 AM were injected intravenously with 500 mg of Triton
WR1339 (Sigma) per kg body weight as a 15 g/dl solution in
0.9% NaCl to block plasma VLDL clearance. Blood samples
were taken at 0, 1, 2, 3, and 4 hours after Triton WR1339
injection. Plasma triglycerides were analyzed enzymatically as
described above. The hepatic VLDL production rate was
calculated from the slope of the curve and expressed as
mg/ml/h.
Analysis of gene expression by real-time quantitative
PCR
Quantitative gene expression analysis was performed as
described [16]. Total RNA was isolated according to
Chomczynski and Sacchi [17] and reverse transcribed using
RevertAidTM reverse transcriptase. Gene expression analysis
was performed using real-time SYBR Green technology
(Eurogentec). Primer sequences can be provided on request.
Beta-actin (ACTB) and acidic ribosomal phosphoprotein P0
(36B4) were used as the standard housekeeping genes.
Relative gene expression numbers were calculated by
subtracting the threshold cycle number (Ct) of the target gene
from the average Ct of beta-actin and 36B4 (Ct housekeeping)
and raising 2 to the power of this difference. Genes that
exhibited a Ct value of >35 were considered not detectable.
The average Ct of two housekeeping genes was used to
exclude that changes in the relative expression were caused by
variations in the expression of the separate housekeeping
genes.
Data Analysis
Data are presented as means±SEM. Statistical analysis was
performed using Graphpad Instat software (San Diego, USA,
http://www.graphpad.com). Normality testing of the
experimental groups was performed using the method
Kolmogorov and Smirnov (Graphpad Instat). The significance
of differences was calculated using a two-tailed Student’s t test
or two way analysis of variance (ANOVA) with Bonferroni post-
test where appropriate. Probability values less than 0.05 were
considered significant.
Results
APOE knockout mice were subjected to bilateral
adrenalectomy (ADX) to diminish their glucocorticoid function.
In line with an essential role for the adrenals in the secretion of
glucocorticoids, adrenalectomized APOE knockout mice
exhibited markedly decreased plasma levels of corticosterone -
the primary glucocorticoid circulating in mice - as compared to
SHAM-operated control mice under basal conditions (12 ± 2
ng/ml vs 139 ± 14 ng/ml: P<0.001; Figure 1).
Routine blood analysis using a SYSMEX hematological
analyzer revealed no major changes in red blood cell and
platelet numbers and associated parameters (Table 1). In
contrast, a marked increase in the white blood cell count
(WBC; +55%; P<0.001) was noted after adrenalectomy (Table
1). This increase was primarily seen in the lymphocyte (+56%;
P<0.001) and, to a minor extent, monocyte (+25%; P<0.05)
population. Absolute neutrophil numbers were not changed in
response to adrenalectomy, resulting in an overall increase in
the lymphocyte white blood cell percentage (85 ± 1% vs 80 ±
1%; P<0.01) and a parallel decrease in the neutrophil (9.3 ±
0.8% vs 12.3 ± 0.9%; P<0.05) and monocyte fractions (4.2 ±
0.3% vs 5.4 ± 0.4%; P<0.05).
Figure 1.  Adrenalectomized (ADX; N=19) APOE knockout
mice show diminished plasma corticosterone levels as
compared to SHAM-operated mice (N=22).  Values represent
means+SEM. *** P<0.001.
doi: 10.1371/journal.pone.0080441.g001
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To further specify the changes in leukocyte homeostasis we
performed fluorescence activated cell sorting (FACS) analysis.
In accordance with a decrease in the percentage of monocytes
and neutrophils, the level of CD11b-positive cells as
determined by FACS was significantly lower (9.4 ± 0.3% vs
15.7 ± 0.6%; P<0.001) in blood of adrenalectomized mice
(Figure 2A). The activation state of the CD11b-positive cells -
as measured by the presence of the surface marker CD86 –
did not differ between groups (Figure 2A). Importantly, although
the difference did not reach statistical significance due to the
large intra-group variance (P>0.05), basal plasma levels of
interleukin-6 were 51% higher in adrenalectomized mice
(217±43 pg/ml; N=11) as compared to SHAM-operated controls
(144±37 pg/ml; N=12). This indicates that cytokine secretion by
macrophages was probably increased, which concurs with a
more pro-inflammatory immune state in adrenalectomized
mice.
Despite an identical expression level of CD86 on B-
lymphocytes, the blood of adrenalectomized mice was
significantly enriched in CD19-positive cells (55 ± 2% in ADX
vs 46 ± 1% in SHAM; P<0.01; Figure 2B). The spleen serves
as an important reservoir of B-cells. In further support of a
generally higher systemic inflammatory status due to removal
of the glucocorticoid function, spleen weight increased from 92
± 6 mg in SHAM-operated mice to 123 ± 7 mg in
adrenalectomized mice (P<0.01; Figure 3). However, FACS
analysis did not reveal differences in the relative number
(Figure 3) or activation state (data not shown) of splenic
CD11b-positive cells and B- and T-lymphocyte populations.
In both groups of mice, CD4-positive T-helper cells (Figure
2C) and CD8-positive cytotoxic T-lymphocytes (Figure 2D)
constituted 11-16% of total blood leukocytes. We detected a
significant change in the T-lymphocyte maturity level upon
adrenalectomy. The fraction of cells expressing the immaturity
Table 1. Comparison of hematological parameters in the
experimental groups.
Parameter SHAM (N=12) ADX (N=11) P-value
Red blood cells (10E12/L) 10.0 ± 0.1 10.2 ± 0.2 > 0.05
MCV (fL) 49.5 ± 0.4 48.9 ± 0.2 > 0.05
HCT (%) 49.7 ± 0.4 49.9 ± 0.7 > 0.05
RDW-SD (fL) 30.8 ± 0.2 32.2 ± 0.3 < 0.01
Platelets (10E9/L) 1002 ± 63 988 ± 56 > 0.05
MPV (fL) 6.73 ± 0.04 6.73 ± 0.03 > 0.05
PCT (%) 0.68 ± 0.04 0.66 ± 0.04 > 0.05
PDW (fL) 7.50 ± 0.04 7.55 ± 0.07 > 0.05
White blood cells (10E9/L) 6.5 ± 0.5 10.0 ± 0.4 < 0.001
Neutrophils (10E9/L) 0.83 ± 0.10 1.11 ± 0.16 > 0.05
Lymphocytes (10E9/L) 5.4 ± 0.4 8.4 ± 0.4 < 0.001
Monocytes (10E9/L) 0.35 ± 0.03 0.44 ± 0.02 < 0.05
Eosinophils (10E9/L) 0.14 ± 0.02 0.17 ± 0.01 > 0.05
Neutrophils (%) 12.3 ± 0.9 9.3 ± 0.8 < 0.05
Lymphocytes (%) 80.2 ± 1.0 84.5 ± 0.7 < 0.01
Monocytes (%) 5.4 ± 0.5 4.2 ± 0.3 < 0.05
Eosinophils (%) 2.0 ± 0.2 1.6 ± 0.1 < 0.05
doi: 10.1371/journal.pone.0080441.t001
marker CD62L was respectively 34% (P<0.001) and 22%
(P<0.05) higher for CD4-positive and CD8-positive cells in the
ADX group as compared to the SHAM-operated group in blood
(Figure 2C/2D). Taking the 1.5-fold increase in total white blood
cell numbers into account, it thus appears that
adrenalectomized mice show a marked increase in the
absolute number of immature (+102% for CD4; +84% for CD8)
but not in mature T-lymphocytes. Thymus weight was not
significantly different in the two groups of mice (Figure 4).
However, a marginal but significant increase in the fraction of
CD4/CD8 double positive thymocytes could be observed in
ADX mice (93.0 ± 0.2% vs 91.1 ± 1.4%; P<0.05; Figure 4).
Together, these findings suggest a stimulated development in
and secretion of naïve T-cells from the thymus upon removal of
the glucocorticoid function by adrenalectomy.
To analyze the impact of adrenalectomy on the sepsis
susceptibility adrenalectomized mice and SHAM controls were
subjected to a sub-lethal dose of lipopolysaccharide (LPS; 50
μg/kg) to stimulate secretion of the pro-inflammatory cytokine
tumor necrosis factor-alpha (TNF-alpha) by macrophages. As
depicted in Figure 5, only SHAM-operated mice were able to
increase the plasma level of corticosterone in response to the
LPS-induced pro-inflammatory trigger. TNF-alpha levels were
not detected in plasma of adrenalectomized or SHAM-operated
mice that had not been subjected to a pro-inflammatory trigger.
As expected, LPS exposure induced a time-dependent
increase in plasma levels of TNF-alpha in SHAM-operated
mice. Importantly, adrenalectomy markedly stimulated the LPS-
induced TNF-alpha response (Figure 5). This was paralleled by
such severe disease symptoms (immobility; hypothermia) that
the adrenalectomized mice had to be euthanized early, i.e.
after 2.5 hours into the experiment. It thus seems that in APOE
knockout mice glucocorticoids do efficiently execute their anti-
inflammatory function and thereby protect against induction of
(fatal) endotoxemia.
Development of atherosclerotic lesions is a slow process that
progresses over a period of weeks or months depending on the
type of genetically modified mice and diet used. To study the
impact of the glucocorticoid function on the initial phase of
atherosclerotic lesion development in our APOE knockout
mice, we performed ADX or SHAM operations in age-matched
5- to 6-week old mice and subsequently waited for 8 weeks for
lesions to develop while feeding the mice a regular chow low
fat diet without added cholesterol. As evident from Figure 6A,
adrenalectomy did not increase the susceptibility for the
development of initial atherosclerotic lesions. Both groups of
operated mice exhibited a similar extent of atherosclerosis
development at the aortic root with respective lesion sizes of
112 ± 17 x 103 μm2 for SHAM-operated mice and 84 ± 9 x 103
μm2 for ADX mice. In line with the macrophage-rich fatty streak
lesion stage, virtually no collagen was detected in any of the
lesions in either experimental group (<1%; data not shown).
Since the effect of interventions in the atherogenic process
may dependent on the stage of lesion development, we also
examined the impact of glucocorticoid depletion on the
progression of atherosclerotic lesions from the initial
macrophage-rich stage to more advanced collagen-containing
plaques. Hereto, we executed the adrenalectomy in age-
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matched 14 weeks old mice and quantified the lesion content
at 22 weeks of age. Similarly as observed for the initial
development of atherosclerotic lesions, progression of initial
lesions to more advanced atherosclerotic plaques was
unaffected by adrenalectomy (Figure 6B). Both groups of
operated mice displayed aortic root lesions of about 370 x 103
μm2 that contained significant amounts of collagen (8-9% of
total lesion area). In contrast to the increased sepsis severity
noted after adrenalectomy, the higher inflammatory status
associated with removal of the glucocorticoid function thus did
not translate into a stimulated susceptibility for atherosclerotic
lesion development.
Recent studies have suggested a new role for endogenous
glucocorticoids in the suppression of intestinal cholesterol
absorption [18]. We measured the postprandial triglyceride
response upon an oral fat load to determine whether
glucocorticoids also inhibit intestinal triglyceride mobilization.
Ad libitum-fed basal plasma triglyceride levels were low and not
different between the two groups of mice (98±13 mg/dl for ADX
(n=10) vs 99±7 mg/dl for SHAM (n=15); P>0.05).
Administration of a bolus of olive oil induced a time-dependent
increase in plasma triglyceride levels in SHAM-operated mice,
which peaked at 2 hours and returned to basal levels 4 hours
after the treatment (Figure 7A). The peak of the increase in
triglyceride levels and the area-under-the-curve of the total
Figure 2.  Adrenalectomy in APOE knockout mice decreases blood relative monocyte counts (A), increases B-lymphocyte
numbers (B), and keeps T-helper cells (C) and cytotoxic T-cells (D) in a more immature state.  Values represent means+SEM
of 5 mice per group. *P<0.05, ** P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080441.g002
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postprandial response were respectively 2.5-fold and 2.7-fold
higher in ADX mice (P<0.05 for both; Figure 7A). In line with
the notion that the increase in the postprandial triglyceride
response was due to increased intestinal lipid absorption, we
did not detect a change in the hepatic expression level of the
key lipolytic enzyme lipoprotein lipase (LPL; data not shown).
Strikingly, plasma total cholesterol levels were decreased in
adrenalectomized mice (Two-way ANOVA P<0.001 for ADX;
Figure 7B), with a 20% decrease (P<0.01) four weeks post
surgery and a marked 35% decrease (P<0.001) at sacrifice 8
weeks post ADX. Lipoprotein distribution analysis revealed that
the decrease in total cholesterol noted after 4 weeks could be
primarily attributed to a decrease in the level of very-low-
density lipoproteins (VLDL; -34%) – the main lipoprotein
species circulating in blood of APOE knockout mice – as
plasma levels of low-density lipoproteins (LDL; -18%) and high-
density lipoproteins (HDL; +6%) were much less affected
(Figure 7C). Several processes play a crucial role in the control
of steady state plasma VLDL-cholesterol levels, including
secretion of triglyceride-rich VLDL particles by the liver and
removal of VLDL-remnants and LDL from the blood circulation
through receptor-mediated uptake by hepatocytes. To uncover
Figure 3.  Absolute spleen weights (A) and relative amounts of monocytes, B- and T-lymphocyte populations in spleens (B)
of adrenalectomized (ADX) and SHAM-operated APOE knockout mice.  Values represent means+SEM of 5 (FACS data) or
10-15 (spleen weight) mice per group. ** P<0.01.
doi: 10.1371/journal.pone.0080441.g003
Figure 4.  Adrenalectomy in APOE knockout mice does not alter the absolute thymus weight, but increases the thymic
CD4/CD8 double positive lymphocyte fraction.  Values represent means+SEM of 5 (FACS data) or 10-15 (thymus weight) mice
per group. * P<0.05.
doi: 10.1371/journal.pone.0080441.g004
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the mechanism behind the decrease in VLDL levels observed
in ADX mice, the effect of adrenalectomy on hepatic gene
expression levels was determined (Figure 8A). In accordance
with a diminished glucocorticoid signalling in the liver, we noted
a significant decrease in the liver mRNA expression of
glucocorticoid receptor targets tyrosine aminotransferase (TAT;
-28%; P<0.05) and cholesterol 7alpha-hydroxylase (CYP7A1;
-56%; P<0.01). Relative mRNA expression levels of the
lipoprotein receptors CD36, scavenger receptor BI (SR-BI) and
LDL receptor related protein 1 (LRP1) were not different
between groups. LDL receptor (LDLR) transcript levels were
significantly lower in ADX mice (-26%; P<0.05), suggesting a
diminished hepatic clearance of specifically apolipoprotein
B100 (APOB100)-containing lipoproteins. The expression
levels of the rate-limiting enzyme in de novo synthesis of
cholesterol from acetyl-CoA, HMG-CoA reductase (HMGCR),
were not significantly changed. The first committed step of fatty
acid synthesis – the conversion of acetyl-CoA to malonyl-CoA
– did also not seem to be affected as judged from the unaltered
expression of acetyl-CoA carboxylase (ACACA).
Adrenalectomy was, however, associated with a respective
36% and 40% (P<0.05 both) decrease in the expression of fatty
acid synthase (FASN) and stearoyl-Coenzyme A desaturase 1
(SCD1), lipogenic enzymes that carry out essential steps in the
synthesis of fatty acids from acetyl-CoA and malonyl-CoA.
Microsomal triglyceride transfer protein (MTP) and APOB
expression levels were not different between ADX and SHAM
mice, indicative of a similar capacity of the liver to package
triglycerides into APOB-containing VLDL particles. Importantly,
the changes in lipogenic gene expression did translate into an
overall 24% lower (P<0.05; Figure 8B) hepatic secretion rate of
triglyceride-rich VLDL particles.
Discussion
Glucocorticoids are considered to be some of the most
powerful endogenous anti-inflammatory molecules. Both
natural and synthetic glucocorticoids have therefore emerged
as principal therapeutic agents to treat inflammation-based
diseases, such as rheumatoid arthritis (RA) [19] and systemic
lupus erythematosus (SLE) [20]. In the current study, the
impact of removal of the glucocorticoid function through
adrenalectomy on the basal inflammatory status, sepsis
susceptibility, and atherosclerotic lesion development was
evaluated in hyperlipidemic APOE knockout mice. Although we
anticipate that the majority of the effects induced by
adrenalectomy are secondary to disruption of the glucocorticoid
function, it should be noted that ablation of the adrenal
catecholamine and mineralocorticoid function may also have
contributed to the overall outcome of our studies.
In accordance with suppression of the proliferation and
maturation of pro-inflammatory cell types by glucocorticoids,
we observed a rise in the blood leukocyte count and an
increase in spleen weight, which could be primarily attributed to
a higher number of B- and T-lymphocytes and a minor increase
in monocytes. Previous findings from adrenal insufficient
melanocortin receptor 2 knockout mice have already suggested
an important role for endogenous glucocorticoid in B-cell
development. Melanocortin receptor 2 knockout mice display
an increase in all splenic B-cell fractions, which coincided with
a higher number of pre-B cells in the bone marrow [21].
However, a diminished apoptosis rate of mature B cells [22]
may also underlie the increase in B-cell numbers observed
upon adrenalectomy. Based upon our FACS analysis it seems
that the increase in blood T-lymphocyte numbers may originate
from a stimulated production of T-lymphocytes in the thymus as
we detected an increase in the CD4/CD8 double positive
Figure 5.  Adrenalectomized APOE knockout mice fail to increase their plasma corticosterone levels upon exposure to a
sub-lethal dose of LPS, which is associated with a markedly enhanced plasma TNF-alpha response.  Values represent
means+SEM of 5 (SHAM) and 4 (ADX) mice per group. *** P<0.001.
doi: 10.1371/journal.pone.0080441.g005
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thymocyte fraction upon adrenalectomy. These findings concur
with data from Purton et al. on the high sensitivity of double
positive thymocytes for glucocorticoid-induced death [23] and
previous observations of increased double positive thymocyte
numbers in adrenalectomized rats [24] and melanocortin
receptor 2 knockout mice [21].
APOE knockout mice as compared to normolipidemic wild-
type mice display an enhanced susceptibility to endotoxemia
[6,7]. Our present study suggests that the enhanced
glucocorticoid levels in APOE knockout mice protect against
(lethal) sepsis, since adrenalectomy in APOE knockout mice
was associated with a concomitant higher susceptibility for
septic shock as judged from the increased TNF-alpha response
and more extreme disease symptoms / lethality upon LPS
exposure. Monocyte lineages play an essential role in the
pathogenesis of endotoxemia as monocyte-derived
macrophages secrete pro-inflammatory cytokines that - when
their levels reach an upper threshold level - induce septic
shock. The higher endotoxemia susceptibility may therefore in
part directly result from the monocytosis observed upon
adrenal removal. However, glucocorticoids can also diminish
the secretion of pro-inflammatory cytokines by leukocytes and
endothelial cells through inhibition of NFkappaB action [25],
which may also explain the increase in plasma TNF-alpha
Figure 6.  Adrenalectomy does not alter the size (A) or collagen content (B) of atherosclerotic lesions in APOE knockout
mice.  Representative neutral lipid (Oil red O) and collagen (Trichrome: blue) stainings of early (C) and advanced (D) aortic root
lesions. Separate dots in figures A and B represent values for each individual mouse, while horizontal lines indicate the respective
group averages.
doi: 10.1371/journal.pone.0080441.g006
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levels in ADX mice. Furthermore, our data clearly indicate that,
although APOE may exhibit potent anti-inflammatory
properties, its presence is not essential for the protection of
glucocorticoids against inflammation.
Relatively high numbers of blood leukocytes are significant
contributors to cardiovascular disease - i.e. coronary artery
disease and ischemic heart disease - in the human situation
[26-30]. In striking contrast to the marked increase in sepsis
Figure 7.  Plasma postprandial triglyceride response (A), cholesterol levels (B), and lipoprotein profiles (C) in
adrenalectomized (ADX) and SHAM-operated APOE knockout mice.  VLDL, very low-density lipoprotein; LDL, low-denisty
lipoprotein; HDL, high-density lipoprotein. Values represent means+SEM or 5 mice per group. * P<0.05, ** P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080441.g007
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susceptibility, the leukocytosis observed upon adrenalectomy
however did not affect either the initiation or progression of
atherosclerotic lesions in our APOE knockout mice. Our data
further highlight the complexity regarding the effect of
glucocorticoids on atherosclerotic lesion development and
cardiovascular disease incidence. In the human situation, low
glucocorticoid levels as observed in Addison’s disease (primary
adrenal insufficiency) are associated with a higher
cardiovascular mortality rate as well as an increased rate of
death due to infectious diseases [31], which is probably related
to the diminished glucocorticoid-mediated anti-inflammatory
action. In parallel, adrenalectomy stimulated atherosclerotic
lesion development in atherosclerosis-susceptible LDL receptor
knockout mice fed a pro-inflammatory cholic acid-containing
atherogenic diet [9]. In contrast, disruption of glucocorticoid
receptor function in macrophages alters the intra-plaque
calcification rate but does not affect atherosclerotic lesion size
in Western-type diet-fed LDL receptor knockout mice [32].
Patients suffering from Cushing’s syndrome –
hypercortisolemia – do actually also exhibit an enhanced risk
for cardiovascular disease [33]. This has been attributed to the
pro-atherogenic metabolic phenotype (i.e. diabetes,
hypertension) associated with long-term high plasma
glucocorticoid levels. Lowering of plasma pro-atherogenic lipid
levels by statin treatment is the primary intervention to
effectively reduce the cardiovascular disease risk in human
subjects [34]. Importantly, in the current study we detected a
significant decrease in VLDL-cholesterol levels that could be
explained by a diminished secretion of triglyceride-rich VLDL
particles by the liver as a result of decreased hepatic
lipogenesis. It is therefore anticipated that the absence of a
pro-atherogenic outcome in response to the leukocytosis
associated with adrenalectomy may be attributed to a parallel
decrease in the pro-atherogenic lipid trigger. In accordance,
disruption of specifically glucocorticoid’s metabolic function
through administration of an 11β-hydroxysteroid
dehydrogenase type 1 (11β-HSD1) inhibitor is able to improve
the plasma lipoprotein profile and decrease atherosclerotic
plaque load in APOE knockout mice [35] and agouti LDL
receptor knockout mice [36]. From these combined findings it
appears that a sensitive balance between anti-inflammatory /
anti-atherogenic actions and pro-atherogenic metabolic
consequences of glucocorticoids exists that determines the
overall outcome of the atherosclerosis and cardiovascular
disease. From a therapeutical point of view it thus seems of
critical importance to take into account both the general
metabolic and inflammatory status of human subjects upon
treatment of glucocorticoid-related diseases or when
administering glucocorticoid-based drugs, especially if one also
Figure 8.  Relative gene expression levels in liver (A) and hepatic VLDL-triglyceride secretion rates (B) of adrenalectomized
(ADX) and SHAM-operated APOE knockout mice.  Values represent means+SEM of 5-8 mice per group. * P<0.05, ** P<0.01.
doi: 10.1371/journal.pone.0080441.g008
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considers the potent protective properties of glucocorticoids in
the context of sepsis and other inflammatory pathologies.
In conclusion, our studies show that adrenalectomy induces
leukocytosis and enhances the susceptibility for endotoxemia
in APOE knockout mice. The adrenalectomy-associated rise in
white blood cells, however, does not alter atherosclerotic lesion
development probably due to the parallel decrease in plasma
levels of pro-atherogenic lipoproteins.
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